PDF下载 ( 129 KB)
Effect of combination treatment of Adefovir and r-IFN to the hepatic fibrosis caused by hepatitis B
-
摘要: 目的探讨阿德福韦酯联合r-干扰素对慢性乙型肝炎肝纤维化指标的影响。方法对我院2006年门诊及住院的慢性乙型肝炎患者随机分为阿德福韦酯联合r-干扰素组（A组35例）、单用阿德福韦酯组（B组30例）,两组进行对照临床观察。结果A组治疗后效果明显优于B组（P<0.01）。结论在使用阿德福韦酯抗病毒治疗的同时联合使用r-干扰素治疗慢性乙型肝炎能较好地提高抗肝纤维化的治疗效果。Abstract: Objective The aim was to discuss the effect of combination treatment of Adefovir and r-IFN to the hepatic fibrosis caused by chronic hepatitis B.Methods Sixty-five CHB patients were divided into two groups of A (35 patients with the combination treatment of Adefovir and rIFN) and B (30 patients with mono-Adefovir) randomly.Then compare the results of the two groups.Results Result of Group A is significantly better than Group B (P<0.01) .Conclusion Using Adefovir for antivirus treatment combining with r-IFN to treat chronic hepatitis B can preferably improve the effect of anti-hepatic fibrosis treatment.
-
Key words:
- adefovir /
- hepatic fibrosis /
- r-IFN /
- combination treatment
-
[1]中华医学会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) ∶56-62. [2]Friedman SL.Liver fibrosis-from bench to bedside[J].J Hepatol, 2003, 38 (Suppl 1) ∶S38-53. [3]姚光弼.慢性乙型肝炎长期抗病毒治疗的目标与策略[J].中华传染病杂志, 2005, 23 (Sup) ∶7-10. [4]范中善.干扰素的临床应用[M].北京:北京医科大学出版社, 1996∶110-124. [5]愈纯山.肝纤维化的检测及其临床意义[J].中华检验医学杂志, 2000, 3∶190. [6]赵根成, 王玉忠, 李芳.慢性肝炎肝纤维化程度与B超探测门静脉、脾静脉内径及脾厚关系的探讨[J].中西医结合肝病杂志, 2001, 1∶36-37. -
本文二维码
计量
- 文章访问数: 2051
- HTML全文浏览量: 14
- PDF下载量: 851
- 被引次数: 0
下载:
